Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group
Research output: Contribution to journal › Review article › peer-review
Authors
Colleges, School and Institutes
External organisations
- Cleveland Clinic
Abstract
Interventional (or therapeutic) inflammatory bowel disease (IBD) endoscopy has an expanding role in the treatment of disease and surgical adverse events. Endoscopic therapy has been explored and used in the management of strictures, fistulas/abscesses, colitis-associated neoplasia, postsurgical acute or chronic leaks, and obstructions. The endoscopic therapeutic modalities include balloon dilation, stricturotomy, stent placement, fistulotomy, fistula injection and clipping, sinusotomy, EMR, and endoscopic submucosal dissection. With a better understanding of the disease course of IBD, improved long-term impact of medical therapy, and advances in endoscopic technology, we can foresee interventional IBD becoming an integrated part of the multidisciplinary approach to patients with complex IBD.
Details
Original language | English |
---|---|
Pages (from-to) | 215-237 |
Number of pages | 23 |
Journal | Gastrointestinal Endoscopy |
Volume | 89 |
Issue number | 2 |
Early online date | 24 Oct 2018 |
Publication status | Published - 1 Feb 2019 |
Keywords
- IBD, Endoscopy